NOVA LEAH LIMITED

Nova Leah Limited is a world‑leader in cybersecurity risk‑management for connected devices, serving both medical‑device manufacturers and system integrators. Leveraging AI‑driven platforms, the company helps clients meet stringent regulatory frameworks such as NIS2, CRA, DORA, HIPAA, FDA 524B and EU MDR/IVDR, turning complex compliance into a seamless, continuous process.

Its flagship solutions are the SelectEvaluate® suite – a single‑point portal that standardises third‑party cyber risk across multi‑vendor estates, from procurement through decommissioning, with live risk dashboards, automated SBOM monitoring and coordinated vulnerability disclosure. For manufacturers of connected medical technologies, SelectEvidence™ embeds security‑by‑design into the product lifecycle, providing 24/7 evidence collection, automated mitigation, and audit‑ready reporting that align with global medical‑device regulations.

Headquartered in Ireland with an office in Dundalk, Co Louth, Nova Leah also operates a US hub in Boston, enabling a truly global support network. Its clear onboarding process, free five‑day evaluation and specialist expertise make it a trusted partner for organisations seeking to safeguard their connected devices and supply‑chain resilience.